Magdalena Rogalska

539 citations
24 papers · 353 indexed · h-index 9

Magdalena Rogalska

22 papers receiving 345 citations

Peers

Magdalena Rogalska
Comparison fields: 5 of 70
  • Hepatology 150
  • Immunology 95
  • Epidemiology 144
  • Genetics 26
  • Infectious Diseases 45
Replace Carl Janssen with:
Carl Janssen Belgium
Martin Coenen Germany
Harshna Patel Canada
Anne McCune United Kingdom
Soo Hyung Ryu South Korea
Tomoo Yamazaki Japan
Jota Watanabe Japan
Ying‐Ming Chiu Taiwan
Chunfang Gao China
Motohiro Arao Japan
Magdalena Rogalska relative to Carl Janssen Belgium Carl Janssen's profile →
Citations per field
00.5×3.3×
Carl Janssen · 1×
Citations per year

Countries citing papers authored by Magdalena Rogalska

Since Specialization
Citations

This map shows the geographic impact of Magdalena Rogalska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Rogalska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Rogalska more than expected).

Fields of papers citing papers by Magdalena Rogalska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdalena Rogalska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Rogalska. The network helps show where Magdalena Rogalska may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Magdalena Rogalska, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Magdalena Rogalska Line = papers co-authored together Magdalena Rogalska links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2 20245
3 20231
4 20172
5 20152
6 20155
7
Galectin-3 Concentration in Liver Diseases.
201542
8 20142
9 20145
10 201417
11 201381
12 201124
13 201034
14 20100
15 200821
16 200831
17 20068
18 200625
19
Oportunistyczne inwazje pasozytnicze zagrazajace czlowiekowi
20053
20 20056

About Magdalena Rogalska

Magdalena Rogalska is a scholar working on Hepatology, Epidemiology and Genetics, having authored 24 papers that have together received 353 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (5 papers), Liver Disease and Transplantation (4 papers), Iron Metabolism and Disorders (3 papers), Hemoglobinopathies and Related Disorders (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Chronic Kidney Disease and Diabetes (2 papers). The work is most often cited by research in Hepatology (150 citations), Immunology (95 citations) and Epidemiology (144 citations). Magdalena Rogalska has collaborated with scholars based in Poland, Germany and United States. Frequent co-authors include Jerzy Jaroszewicz, Iwona Flisiak, Robert Flisiak, Bożena Chodynicka, Michael P. Manns, Heiner Wedemeyer, Antoaneta A. Markova, Markus Cornberg, Benjamin Maasoumy and Kerstin Port. Their work appears in journals such as PLoS ONE, Journal of Hepatology and Journal of Leukocyte Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026